Singular Genomics Systems Inc - רווח נקי למניה (EPS TTM) OMIC

High barriers to entry and G4 patents protect the margins of Singular Genomics Systems (OMIC) from new entrants. The annual net income per share TTM growth trend on the GURU.Markets chart demonstrates a price vector where -2.00 captures the magnitude of this parameter. Singular Genomics Systems (OMIC) wins the competition through analysis speed, while stable equipment sales are ensured by the delivery of sequencing systems to research centers.

The development of G4 sequencing systems through partnerships with research institutes is directly reflected in the year-over-year EPS dynamics for Singular Genomics Systems (OMIC) over the last 12 months. This indicator measures the rate of change in earnings per share using a TTM rolling window to smooth out quarterly volatility. The calculation is based on a comparison of current annual earnings with the same period last year. The growth of this metric confirms the effectiveness of the synergy from joint projects; however, the trend warrants caution when assessing the business's market valuation.